KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Non-Current Deffered Revenue (2016 - 2020)

Historic Non-Current Deffered Revenue for Rigel Pharmaceuticals (RIGL) over the last 12 years, with Q3 2020 value amounting to $146000.0.

  • Rigel Pharmaceuticals' Non-Current Deffered Revenue fell 9942.01% to $146000.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $146000.0, marking a year-over-year decrease of 9942.01%. This contributed to the annual value of $1.4 million for FY2019, which is 28.41% down from last year.
  • As of Q3 2020, Rigel Pharmaceuticals' Non-Current Deffered Revenue stood at $146000.0, which was down 9942.01% from $1.6 million recorded in Q1 2020.
  • In the past 5 years, Rigel Pharmaceuticals' Non-Current Deffered Revenue ranged from a high of $26.4 million in Q2 2019 and a low of $90000.0 during Q4 2017
  • In the last 5 years, Rigel Pharmaceuticals' Non-Current Deffered Revenue had a median value of $1.4 million in 2018 and averaged $6.3 million.
  • As far as peak fluctuations go, Rigel Pharmaceuticals' Non-Current Deffered Revenue surged by 1472078.65% in 2019, and later tumbled by 9942.01% in 2020.
  • Over the past 5 years, Rigel Pharmaceuticals' Non-Current Deffered Revenue (Quarter) stood at $279000.0 in 2016, then tumbled by 67.74% to $90000.0 in 2017, then skyrocketed by 1464.44% to $1.4 million in 2018, then dropped by 0.28% to $1.4 million in 2019, then crashed by 89.6% to $146000.0 in 2020.
  • Its Non-Current Deffered Revenue stands at $146000.0 for Q3 2020, versus $1.6 million for Q1 2020 and $1.4 million for Q4 2019.